Melanoma, Darwinian medicine and the inner world
- PMID: 20852885
- PMCID: PMC2962785
- DOI: 10.1007/s00432-010-0949-x
Melanoma, Darwinian medicine and the inner world
Abstract
Introduction: A diverse range of human diseases, including allergy, asthma, autoimmune disease, cancer and chronic neurologic diseases, notably multiple sclerosis and endogenous depression, is becoming more prevalent in industrialized countries. It has been postulated that environmental factors associated with improved standards of hygiene play a leading role in this process since the immune system seems to need extrinsic challenges for its proper maturation.
The inner world: An added dimension has now emerged--the impact on disease of the inner world, principally the numerous endogenous retroviruses (HERVs) within the human genome. Taking melanoma as an example, we propose a framework for understanding how a complex infectious and immunological background can induce or inhibit expression of a HERV-related disease process. The central role of a failure to induce or to maintain certain populations of self-specific CD8(+) T-cells mediating immune surveillance, the expression of HERV-encoded peptides on affected cells and pathological mechanisms directly attributable to HERV proteins are discussed.
Conclusions: The presented concepts explain events preceding the clinical manifestation of diseases by several years and provide a rationale for the use of currently available vaccines to protect against certain HERV-induced diseases, especially melanoma. Criteria for establishing the causal role of HERVs in a given disease are proposed.
Similar articles
-
Human endogenous retroviruses and cancer prevention: evidence and prospects.BMC Cancer. 2013 Jan 3;13:4. doi: 10.1186/1471-2407-13-4. BMC Cancer. 2013. PMID: 23282240 Free PMC article.
-
HIV infection and HERV expression: a review.Retrovirology. 2012 Jan 16;9:6. doi: 10.1186/1742-4690-9-6. Retrovirology. 2012. PMID: 22248111 Free PMC article. Review.
-
Status of HERV in human cells: expression and coding capacity of human proviruses.Dev Biol (Basel). 2001;106:439-41; discussion 465-75. Dev Biol (Basel). 2001. PMID: 11761259
-
The role of human endogenous retroviruses in melanoma.Br J Dermatol. 2009 Dec;161(6):1225-31. doi: 10.1111/j.1365-2133.2009.09415.x. Epub 2009 Jul 20. Br J Dermatol. 2009. PMID: 19785608 Review.
-
Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.Eur J Cancer. 2005 Jan;41(1):104-17. doi: 10.1016/j.ejca.2004.08.010. Eur J Cancer. 2005. PMID: 15617995
Cited by
-
Paradigms in multiple sclerosis: time for a change, time for a unifying concept.Inflammopharmacology. 2011 Aug;19(4):187-95. doi: 10.1007/s10787-011-0084-6. Epub 2011 May 6. Inflammopharmacology. 2011. PMID: 21547536 Free PMC article.
-
The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.BMC Cancer. 2014 Aug 16;14:595. doi: 10.1186/1471-2407-14-595. BMC Cancer. 2014. PMID: 25128300 Free PMC article. Review.
-
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.Virol J. 2012 Sep 8;9:188. doi: 10.1186/1743-422X-9-188. Virol J. 2012. PMID: 22958517 Free PMC article.
-
Human endogenous retroviruses and the nervous system.Handb Clin Neurol. 2014;123:465-85. doi: 10.1016/B978-0-444-53488-0.00022-5. Handb Clin Neurol. 2014. PMID: 25015500 Free PMC article. Review. No abstract available.
-
Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study.Eur J Cancer Prev. 2018 Jul;27(4):303-309. doi: 10.1097/CEJ.0000000000000333. Eur J Cancer Prev. 2018. PMID: 27870643 Free PMC article.
References
-
- Balada E, Ordi-Ros J, Vilardell-Tarrés M (2009) Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity. Rev Med Virol 19:273–286. doi:10.1002/rmv.622 - PubMed
-
- Boller K, Schönfeld K, Lischer S, Fischer N, Hoffmann A, Kurth R, Tönjes RR (2008) Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol 89(Pt 2):567–572. doi:10.1099/vir.0.83534-0 - PubMed
-
- Bottasso O, Docena G, Stanford JL, Grange JM (2009) Chronic inflammation as a manifestation of defects in immunoregulatory networks–implications for novel therapies based on microbial products. Inflammopharmacol 17:193–203. doi:10.1007/s10787-009-0008-x - PubMed
-
- Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM (2008) Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol 82:9329–9336. doi:10.1128/JVI.00646-08 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials